← Back to All Filings

Moderna CFO Sells $9.3k in MRNA Stock for Tax Withholding

Low SignificanceDecember 1, 2025 at 4:32:36 PM EST

Moderna, Inc.

$MRNA4CIK: 0001682852

Subscribe to track MRNA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Moderna CFO Sells $9.3k in MRNA Stock for Tax Withholding

Company: Moderna, Inc. (MRNA) Form: 4 | Filed: 2025-12-01 Significance: Low

Insider: Mock James M Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 374 • Price: $24.75 • Value: $9,266 • Owned After: 18,658

Key Insight: This is a routine, non-discretionary sale to cover tax obligations from vesting restricted stock units (RSUs). It does not indicate a change in the insider's outlook on the company.

Market Context: The transaction value represents a negligible fraction of Moderna's $9.68 billion market capitalization.

Comprehensive Analysis

SEC Filing Analysis: Moderna, Inc. (MRNA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Financial Officer of Moderna disposed of shares in a non-discretionary transaction to cover tax liabilities arising from the vesting of Restricted Stock Units (RSUs).
  • Market Impact: Neutral. This type of transaction is routine for executive compensation and is not considered an indicator of insider sentiment.

Company Information

FieldValue
CompanyModerna, Inc.
Ticker SymbolMRNA
CIK0001682852
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameMock James M
CIK0001736359
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

This filing reports the vesting of RSUs and a subsequent automatic sale to cover taxes. The primary transaction analyzed is the disposition for tax purposes.

FieldValue
Form Type4
Transaction Date2025-11-26
Transaction CodeF - Payment of tax liability by withholding security
Security TypeCommon Stock
Shares Involved374
Price Per Share$24.75
Total Value$9,265.50
Shares Owned After18,658
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$9,265.50
% of Market Cap<0.0001%
Shares Transacted374
% of Shares OutstandingNot Available
Post-Transaction Ownership18,658 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of approximately $9.3k is insignificant when compared to Moderna's market capitalization of $9.68 billion.
  • Transaction Significance: The filing indicates this was a sale to cover tax withholding obligations (Code 'F') related to the vesting of RSUs (Code 'M'). Such transactions are pre-planned or automatic and do not reflect discretionary investment decisions by the insider. Therefore, the trading significance is low.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a routine part of an executive compensation plan. The market typically does not react to tax-withholding sales as they are not indicative of an insider's sentiment towards the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. This filing provides no bullish or bearish signal.

Additional Context

Transaction Notes

  • Special Circumstances: The filing shows two sets of transactions. First, the acquisition of 773 shares of common stock upon the vesting of RSUs (Code 'M'). Second, the immediate disposition of 374 of those shares to satisfy tax obligations (Code 'F'). This is a standard procedure for equity compensation.
Topics:#SECFiling#InsiderTrading#Moderna#MRNA#Form4#StockMarket#Finance#CFO

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.